IPRs in biobanking- risks and opportunities for translational research
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
IPRs in biobanking- risks and opportunities for translational research. / Minssen, Timo; Verlinden, Michiel; Huys, Isabelle .
In: Intellectual Property Quarterly, Vol. 2015, No. 2, 06.2015, p. 106-129.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - IPRs in biobanking- risks and opportunities for translational research
AU - Minssen, Timo
AU - Verlinden, Michiel
AU - Huys, Isabelle
PY - 2015/6
Y1 - 2015/6
N2 - The gradual shift from traditional closed innovation systems to more “open” and “transparent” innovation models, rapid technological advances and bio-pharmaceutical innovation gaps have highlighted the importance of an effective governance and use of biobanks. This raises important legal questions such as how to deal with intellectual property rights (‘IPRs’) that might arise out of the collection and use of samples and data in research. Only a few projects highlighted the opportunities and potential benefits of user-generated solutions and proper governance of IPRs. This paper aims to provide an overview and analysis of the most relevant IPRs in biobanking and to discuss the challenges and opportunities associated with an effective use of biobanks in translational research and innovation. Section 1 specifies challenges in finding a balance between an open and a close collaboration model. Section 2 will analyze and discuss potential strategies and options to stimulate the exchange of HBM, data and research results. It will also look into the question of how to address, govern and manage IPRs directed to biobank material and data. This will ultimately allow us to draw conclusions in section 3.
AB - The gradual shift from traditional closed innovation systems to more “open” and “transparent” innovation models, rapid technological advances and bio-pharmaceutical innovation gaps have highlighted the importance of an effective governance and use of biobanks. This raises important legal questions such as how to deal with intellectual property rights (‘IPRs’) that might arise out of the collection and use of samples and data in research. Only a few projects highlighted the opportunities and potential benefits of user-generated solutions and proper governance of IPRs. This paper aims to provide an overview and analysis of the most relevant IPRs in biobanking and to discuss the challenges and opportunities associated with an effective use of biobanks in translational research and innovation. Section 1 specifies challenges in finding a balance between an open and a close collaboration model. Section 2 will analyze and discuss potential strategies and options to stimulate the exchange of HBM, data and research results. It will also look into the question of how to address, govern and manage IPRs directed to biobank material and data. This will ultimately allow us to draw conclusions in section 3.
KW - Faculty of Law
KW - Biobank, IPRs, biotechnology, trade secrets
M3 - Journal article
VL - 2015
SP - 106
EP - 129
JO - Intellectual Property Quarterly
JF - Intellectual Property Quarterly
SN - 1364-906X
IS - 2
ER -
ID: 128930973